Global L-Ergothioneine API 麻豆原创 Research Report 2024

Publication ID:

PB508248526

Publication Date:

August 26, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

L-ergothioneine API is an active ingredient with antioxidant, anti-inflammatory, and anti-fatigue effects. It is widely present in various foods, such as mushrooms, oats, green tea, etc.
The global L-Ergothioneine API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
L-ergothioneine API has antioxidant, anti-inflammatory, anti-fatigue and other effects, and has broad application prospects in the medical field. In addition, L-ergothioneine API can also be used in cosmetics, food and other fields. In cosmetics, it can be used as antioxidants, moisturizers and other ingredients to improve the efficacy and safety of cosmetics. In food, it can be used as nutritional supplements, health products and other ingredients to improve the nutritional value and health functions of food. In the future, as market demand continues to increase and technology advances, the application fields of L-ergothioneine API will continue to expand, and market demand will continue to grow.
This report aims to provide a comprehensive presentation of the global market for L-Ergothioneine API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding L-Ergothioneine API.
Report Scope
The L-Ergothioneine API market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global L-Ergothioneine API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the L-Ergothioneine API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Glentham Life Sciences
Mironova Labs
Conagen
Apollo Scientific
Blue California
Avantor
Huarui Biotechnology
Ygingredients
Qingdao Wanyuanshan Biotechnology Co., Ltd.
Shanghai Yuanye Biotechnology Co., Ltd.
Nanjing Daosifu Biotechnology Co., Ltd.
Segment by Type
Water Soluble
Fat Soluble
Segment by Application
Medicines and Health Products
Skin Care Products
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of L-Ergothioneine API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of L-Ergothioneine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 L-Ergothioneine API 麻豆原创 Overview
1.1 Product Overview and Scope of L-Ergothioneine API
1.2 L-Ergothioneine API Segment by Type
1.2.1 Global L-Ergothioneine API 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Water Soluble
1.2.3 Fat Soluble
1.3 L-Ergothioneine API Segment by Application
1.3.1 Global L-Ergothioneine API 麻豆原创 Value by Application: (2024-2030)
1.3.2 Medicines and Health Products
1.3.3 Skin Care Products
1.3.4 Others
1.4 Global L-Ergothioneine API 麻豆原创 Size Estimates and Forecasts
1.4.1 Global L-Ergothioneine API Revenue 2019-2030
1.4.2 Global L-Ergothioneine API Sales 2019-2030
1.4.3 Global L-Ergothioneine API 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 L-Ergothioneine API 麻豆原创 Competition by Manufacturers
2.1 Global L-Ergothioneine API Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global L-Ergothioneine API Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global L-Ergothioneine API Average Price by Manufacturers (2019-2024)
2.4 Global L-Ergothioneine API Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of L-Ergothioneine API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of L-Ergothioneine API, Product Type & Application
2.7 L-Ergothioneine API 麻豆原创 Competitive Situation and Trends
2.7.1 L-Ergothioneine API 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest L-Ergothioneine API Players 麻豆原创 Share by Revenue
2.7.3 Global L-Ergothioneine API 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 L-Ergothioneine API Retrospective 麻豆原创 Scenario by Region
3.1 Global L-Ergothioneine API 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global L-Ergothioneine API Global L-Ergothioneine API Sales by Region: 2019-2030
3.2.1 Global L-Ergothioneine API Sales by Region: 2019-2024
3.2.2 Global L-Ergothioneine API Sales by Region: 2025-2030
3.3 Global L-Ergothioneine API Global L-Ergothioneine API Revenue by Region: 2019-2030
3.3.1 Global L-Ergothioneine API Revenue by Region: 2019-2024
3.3.2 Global L-Ergothioneine API Revenue by Region: 2025-2030
3.4 North America L-Ergothioneine API 麻豆原创 Facts & Figures by Country
3.4.1 North America L-Ergothioneine API 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America L-Ergothioneine API Sales by Country (2019-2030)
3.4.3 North America L-Ergothioneine API Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe L-Ergothioneine API 麻豆原创 Facts & Figures by Country
3.5.1 Europe L-Ergothioneine API 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe L-Ergothioneine API Sales by Country (2019-2030)
3.5.3 Europe L-Ergothioneine API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific L-Ergothioneine API 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific L-Ergothioneine API 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific L-Ergothioneine API Sales by Country (2019-2030)
3.6.3 Asia Pacific L-Ergothioneine API Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America L-Ergothioneine API 麻豆原创 Facts & Figures by Country
3.7.1 Latin America L-Ergothioneine API 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America L-Ergothioneine API Sales by Country (2019-2030)
3.7.3 Latin America L-Ergothioneine API Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa L-Ergothioneine API 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa L-Ergothioneine API 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa L-Ergothioneine API Sales by Country (2019-2030)
3.8.3 Middle East and Africa L-Ergothioneine API Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global L-Ergothioneine API Sales by Type (2019-2030)
4.1.1 Global L-Ergothioneine API Sales by Type (2019-2024)
4.1.2 Global L-Ergothioneine API Sales by Type (2025-2030)
4.1.3 Global L-Ergothioneine API Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global L-Ergothioneine API Revenue by Type (2019-2030)
4.2.1 Global L-Ergothioneine API Revenue by Type (2019-2024)
4.2.2 Global L-Ergothioneine API Revenue by Type (2025-2030)
4.2.3 Global L-Ergothioneine API Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global L-Ergothioneine API Price by Type (2019-2030)
5 Segment by Application
5.1 Global L-Ergothioneine API Sales by Application (2019-2030)
5.1.1 Global L-Ergothioneine API Sales by Application (2019-2024)
5.1.2 Global L-Ergothioneine API Sales by Application (2025-2030)
5.1.3 Global L-Ergothioneine API Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global L-Ergothioneine API Revenue by Application (2019-2030)
5.2.1 Global L-Ergothioneine API Revenue by Application (2019-2024)
5.2.2 Global L-Ergothioneine API Revenue by Application (2025-2030)
5.2.3 Global L-Ergothioneine API Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global L-Ergothioneine API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Glentham Life Sciences
6.1.1 Glentham Life Sciences Corporation Information
6.1.2 Glentham Life Sciences Description and Business Overview
6.1.3 Glentham Life Sciences L-Ergothioneine API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Glentham Life Sciences L-Ergothioneine API Product Portfolio
6.1.5 Glentham Life Sciences Recent Developments/Updates
6.2 Mironova Labs
6.2.1 Mironova Labs Corporation Information
6.2.2 Mironova Labs Description and Business Overview
6.2.3 Mironova Labs L-Ergothioneine API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mironova Labs L-Ergothioneine API Product Portfolio
6.2.5 Mironova Labs Recent Developments/Updates
6.3 Conagen
6.3.1 Conagen Corporation Information
6.3.2 Conagen Description and Business Overview
6.3.3 Conagen L-Ergothioneine API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Conagen L-Ergothioneine API Product Portfolio
6.3.5 Conagen Recent Developments/Updates
6.4 Apollo Scientific
6.4.1 Apollo Scientific Corporation Information
6.4.2 Apollo Scientific Description and Business Overview
6.4.3 Apollo Scientific L-Ergothioneine API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Apollo Scientific L-Ergothioneine API Product Portfolio
6.4.5 Apollo Scientific Recent Developments/Updates
6.5 Blue California
6.5.1 Blue California Corporation Information
6.5.2 Blue California Description and Business Overview
6.5.3 Blue California L-Ergothioneine API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Blue California L-Ergothioneine API Product Portfolio
6.5.5 Blue California Recent Developments/Updates
6.6 Avantor
6.6.1 Avantor Corporation Information
6.6.2 Avantor Description and Business Overview
6.6.3 Avantor L-Ergothioneine API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Avantor L-Ergothioneine API Product Portfolio
6.6.5 Avantor Recent Developments/Updates
6.7 Huarui Biotechnology
6.6.1 Huarui Biotechnology Corporation Information
6.6.2 Huarui Biotechnology Description and Business Overview
6.6.3 Huarui Biotechnology L-Ergothioneine API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Huarui Biotechnology L-Ergothioneine API Product Portfolio
6.7.5 Huarui Biotechnology Recent Developments/Updates
6.8 Ygingredients
6.8.1 Ygingredients Corporation Information
6.8.2 Ygingredients Description and Business Overview
6.8.3 Ygingredients L-Ergothioneine API Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Ygingredients L-Ergothioneine API Product Portfolio
6.8.5 Ygingredients Recent Developments/Updates
6.9 Qingdao Wanyuanshan Biotechnology Co., Ltd.
6.9.1 Qingdao Wanyuanshan Biotechnology Co., Ltd. Corporation Information
6.9.2 Qingdao Wanyuanshan Biotechnology Co., Ltd. Description and Business Overview
6.9.3 Qingdao Wanyuanshan Biotechnology Co., Ltd. L-Ergothioneine API Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Qingdao Wanyuanshan Biotechnology Co., Ltd. L-Ergothioneine API Product Portfolio
6.9.5 Qingdao Wanyuanshan Biotechnology Co., Ltd. Recent Developments/Updates
6.10 Shanghai Yuanye Biotechnology Co., Ltd.
6.10.1 Shanghai Yuanye Biotechnology Co., Ltd. Corporation Information
6.10.2 Shanghai Yuanye Biotechnology Co., Ltd. Description and Business Overview
6.10.3 Shanghai Yuanye Biotechnology Co., Ltd. L-Ergothioneine API Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Shanghai Yuanye Biotechnology Co., Ltd. L-Ergothioneine API Product Portfolio
6.10.5 Shanghai Yuanye Biotechnology Co., Ltd. Recent Developments/Updates
6.11 Nanjing Daosifu Biotechnology Co., Ltd.
6.11.1 Nanjing Daosifu Biotechnology Co., Ltd. Corporation Information
6.11.2 Nanjing Daosifu Biotechnology Co., Ltd. L-Ergothioneine API Description and Business Overview
6.11.3 Nanjing Daosifu Biotechnology Co., Ltd. L-Ergothioneine API Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Nanjing Daosifu Biotechnology Co., Ltd. L-Ergothioneine API Product Portfolio
6.11.5 Nanjing Daosifu Biotechnology Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 L-Ergothioneine API Industry Chain Analysis
7.2 L-Ergothioneine API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 L-Ergothioneine API Production Mode & Process
7.4 L-Ergothioneine API Sales and 麻豆原创ing
7.4.1 L-Ergothioneine API Sales Channels
7.4.2 L-Ergothioneine API Distributors
7.5 L-Ergothioneine API Customers
8 L-Ergothioneine API 麻豆原创 Dynamics
8.1 L-Ergothioneine API Industry Trends
8.2 L-Ergothioneine API 麻豆原创 Drivers
8.3 L-Ergothioneine API 麻豆原创 Challenges
8.4 L-Ergothioneine API 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Glentham Life Sciences
Mironova Labs
Conagen
Apollo Scientific
Blue California
Avantor
Huarui Biotechnology
Ygingredients
Qingdao Wanyuanshan Biotechnology Co., Ltd.
Shanghai Yuanye Biotechnology Co., Ltd.
Nanjing Daosifu Biotechnology Co., Ltd.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.